SEC Form 4 · accession 0001209191-17-059986
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Mauney M.D.
Officer — EVP and Chief Business Officer
Period of report
Nov 8, 2017
Accepted (ET)
Nov 9, 2017 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 8, 2017 | P | 4,270 | $4.68 | A | 58,662 | D |
Table II — derivative securities
No Table II lines on this filing.